Go to deals
Healthcare

Kungshusen Medicinska has been acquired by Diploma

Kungshusen Medicinska AB has been acquired by Diploma PLC. Through the acquisition, Diploma gains access to a unique platform for the distribution of medtech products in Sweden.

Founded in 1977, Kungshusen is a leading Swedish distributor of medtech products in endoscopy and diathermy. The company has established a solid supplier network comprising leading international manufacturers of high-quality products and has built a strong reputation in the market based on its one-stop shop offering, high deliverability and vast sector experience. Headquartered in Mariefred, Kungshusen serves healthcare providers in all major regions of Sweden. Kungshusen’s revenues amount to approximately US$14 million.

Diploma is a UK-listed international group supplying specialized products and services within seals, controls and life sciences. Within the life sciences segment, the company supplies clinical diagnostics instruments and surgical medical devices to hospitals, clinics and laboratories, primarily in Canada, Europe and Australia. Diploma’s revenues amount to approximately US$740 million.

Oaklins’ Swedish team was engaged to run a structured sale process and advised the seller throughout the transaction.

Service
M&A sell-side
Parties
“We are delighted to have found the right new owner of Kungshusen that will leverage the company platform to further expand the business in the future. The Oaklins team has given us excellent support throughout the whole transaction with their professionalism and dedication.”

Henrik Svärdskog

CEO and Co-owner, Kungshusen Medicinska AB

Talk to the deal team

 Adel  Koubaa

Adel Koubaa

Managing Partner

Stockholm, Sweden
Oaklins Sweden
 Lars  Gustafsson

Lars Gustafsson

Partner

Stockholm, Sweden
Oaklins Sweden
 Christos  Karabelas

Christos Karabelas

Associate

Stockholm, Sweden
Oaklins Sweden

Related deals

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Healthcare | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Learn more
Poolbeg Pharma has completed an Initial Public Offering on AIM
Healthcare

Poolbeg Pharma has completed an Initial Public Offering on AIM

Poolbeg Pharma Plc has raised funds to develop the company.

Learn more
Intergrin has raised financing provided by Kartesia
Healthcare

Intergrin has raised financing provided by Kartesia

Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.

Learn more